Geneva Capital Management’s Steris STE Stock Holding History
Bought
Maintained
Sold
Other funds holding STE
OAG
GIM
Geneva Capital Management's STE Position: Q2 2026 in Review
Geneva Capital Management reduced its Steris (STE) stake by 5% in Q2 2026, selling an estimated $1.16M and leaving 103,634 shares worth $21.8M. The position accounts for 0.5% of the portfolio, ranked #57.
Geneva Capital Management first reported a position in STE in Q1 2020 and has held it in 26 quarters since. The position peaked at $36.5M in Q4 2021. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.
- Geneva Capital Management held 103,634 shares of Steris worth $21.8M as of Q2 2026.
- Geneva Capital Management sold 5,417 Steris shares in Q2 2026, an estimated $1.16M.
- Steris made up 0.5% of Geneva Capital Management's portfolio in Q2 2026, its #57 holding.
- Geneva Capital Management first reported a position in Steris in Q1 2020 and has held it in 26 quarters since.
- Geneva Capital Management's Steris position peaked at $36.5M in Q4 2021.
- 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.
Based on Geneva Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.